Riding the pepTIDE — The Daily Wire on Therapeutic Peptides

An independent intelligence board aggregating credible research, preprints, clinical findings, biohacking experiments, and community discussions on therapeutic peptides, longevity science, and evidence-based anti-aging. Stories are scored for relevance, credibility, novelty, momentum, and practicality so the most important findings surface first.

Topic Sections

  • Top Shots — The most significant peptide and longevity stories ranked by overall editorial score
  • Research Signals — High-credibility scientific findings from journals, preprints, and clinical sources
  • Healing & Recovery — Tissue repair, injury recovery, and gut healing peptides including BPC-157 and TB-500
  • Growth Hormone Wire — Growth hormone secretagogues, peptide stacks, and GH axis research including Ipamorelin, CJC-1295, and MK-677
  • Metabolic & GLP-1 — Metabolic health, insulin sensitivity, and GLP-1 receptor agonist research including semaglutide and tirzepatide
  • Cognitive / Nootropic — Peptides targeting brain function, memory, neuroprotection, and cognitive enhancement
  • Skin & Cosmetic — Skin repair, anti-aging, collagen synthesis, and cosmetic peptide research including GHK-Cu and matrixyl
  • Reddit Finds — Community-sourced discussions, self-experimentation reports, and protocol threads from peptide communities
  • Contrarian Takes — Alternative viewpoints, dissenting research, and perspectives that challenge mainstream peptide narratives
  • Skeptic's Corner — Hype debunking, low-evidence alerts, and critical analysis of overstated peptide claims

Browse by Filter

  • Newest — Latest peptide and longevity stories
  • Most Credible — Highest credibility-scored stories
  • Most Edgy — High-novelty, unconventional findings
  • Most Discussed — Trending community discussions
  • Most Actionable — Direct applicability to daily health protocols
  • Lowest Risk — Stories with strong evidence, low hype
  • Research Only — Peer-reviewed and preprint studies
  • Reddit Only — Community discussion and anecdote
  • GLP-1 / Metabolic — Semaglutide, tirzepatide, and metabolic peptides
  • Healing / Recovery — BPC-157, TB-500, and repair protocols

More

  • About Riding the pepTIDE
  • Health Disclaimer
  • Submit a Source
  • Contact

Morning Diarrhea After Mounjaro Dose Increase? Practical Tips and Shared Advice

Someone wrote in saying that after increasing their Mounjaro (tirzepatide) dose to 10 mg, they’ve been getting terrible diarrhea every morning — so bad they race to the bathroom and it sometimes woke them up at night. It happens only first thing in the morning and then stops for the rest of the day. They also mentioned they take Zoloft (an antidepressant) and buspirone (an anxiety medication), and they’re asking for tips and advice. Mounjaro is the brand name for a drug called tirzepatide. It’s a prescription medicine used to treat type 2 diabetes and, in higher doses, is being used for weight loss. It’s not a steroid or stimulant — it’s what scientists call a receptor agonist, which means it mimics natural hormones in your body that help control blood sugar, appetite, and digestion. One of the effects of these gut-hormone drugs is that they slow stomach emptying and change how the intestines handle food and fluids, which can affect bowel habits. This report is an individual anecdote — a single person’s experience — not a controlled study. People taking tirzepatide and similar drugs commonly report gastrointestinal side effects like nausea, vomiting, constipation, and diarrhea. The timing here (morning-only diarrhea after a dose increase) is plausible, because side effects often show up or change after dose adjustments. But from one message you can’t know how common this pattern is, whether it’s caused by Mounjaro, an interaction with Zoloft or buspirone, or something else like diet, an infection, or another medical condition. Why this matters: many people considering or taking Mounjaro want to know about day-to-day quality-of-life impacts. If you find yourself sprinting to the toilet each morning, that affects work, travel, sleep, and mental well-being. Knowing that GI upset is a known possible side effect can help you plan — for example, clinicians may suggest dose adjustments, different timing of meals or meds, or strategies like taking the drug with certain foods. It’s also useful to know that antidepressants and other drugs can influence bowel function, so your full medication list matters. Caveats and risks: since this is a single report, don’t assume everyone will have the same experience. Persistent severe diarrhea can cause dehydration, electrolyte imbalances, and weight loss, and it should be evaluated by a clinician. Don’t stop or change prescription medications without talking to the prescriber. Also, while tirzepatide is approved for diabetes (and similar drugs are used for weight loss), its side effects and interactions are still being learned in real-world use. If symptoms are severe, new, or accompanied by fever, blood in stool, fainting, or severe abdominal pain, seek prompt medical care. Bottom line: Morning-only diarrhea after a dose increase on Mounjaro is a plausible side effect based on what we know, but it’s an anecdote — check with your prescriber before making any changes so they can rule out other causes and help manage the problem.

Source: r/Mounjaro

Read full story

Back to Riding the pepTIDE